These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 27000791)
1. Genetic toxicology at the crossroads-from qualitative hazard evaluation to quantitative risk assessment. White PA; Johnson GE Mutagenesis; 2016 May; 31(3):233-7. PubMed ID: 27000791 [TBL] [Abstract][Full Text] [Related]
2. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations. Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663 [TBL] [Abstract][Full Text] [Related]
3. Opportunities to integrate new approaches in genetic toxicology: an ILSI-HESI workshop report. Zeiger E; Gollapudi B; Aardema MJ; Auerbach S; Boverhof D; Custer L; Dedon P; Honma M; Ishida S; Kasinski AL; Kim JH; Manjanatha MG; Marlowe J; Pfuhler S; Pogribny I; Slikker W; Stankowski LF; Tanir JY; Tice R; van Benthem J; White P; Witt KL; Thybaud V Environ Mol Mutagen; 2015 Apr; 56(3):277-85. PubMed ID: 25482136 [TBL] [Abstract][Full Text] [Related]
4. Empirical analysis of BMD metrics in genetic toxicology part II: in vivo potency comparisons to promote reductions in the use of experimental animals for genetic toxicity assessment. Wills JW; Long AS; Johnson GE; Bemis JC; Dertinger SD; Slob W; White PA Mutagenesis; 2016 May; 31(3):265-75. PubMed ID: 26984301 [TBL] [Abstract][Full Text] [Related]
5. IWGT report on quantitative approaches to genotoxicity risk assessment I. Methods and metrics for defining exposure-response relationships and points of departure (PoDs). MacGregor JT; Frötschl R; White PA; Crump KS; Eastmond DA; Fukushima S; Guérard M; Hayashi M; Soeteman-Hernández LG; Kasamatsu T; Levy DD; Morita T; Müller L; Schoeny R; Schuler MJ; Thybaud V; Johnson GE Mutat Res Genet Toxicol Environ Mutagen; 2015 May; 783():55-65. PubMed ID: 25953400 [TBL] [Abstract][Full Text] [Related]
6. Quantitative approaches for assessing dose-response relationships in genetic toxicology studies. Gollapudi BB; Johnson GE; Hernandez LG; Pottenger LH; Dearfield KL; Jeffrey AM; Julien E; Kim JH; Lovell DP; Macgregor JT; Moore MM; van Benthem J; White PA; Zeiger E; Thybaud V Environ Mol Mutagen; 2013 Jan; 54(1):8-18. PubMed ID: 22987251 [TBL] [Abstract][Full Text] [Related]
7. IWGT report on quantitative approaches to genotoxicity risk assessment II. Use of point-of-departure (PoD) metrics in defining acceptable exposure limits and assessing human risk. MacGregor JT; Frötschl R; White PA; Crump KS; Eastmond DA; Fukushima S; Guérard M; Hayashi M; Soeteman-Hernández LG; Johnson GE; Kasamatsu T; Levy DD; Morita T; Müller L; Schoeny R; Schuler MJ; Thybaud V Mutat Res Genet Toxicol Environ Mutagen; 2015 May; 783():66-78. PubMed ID: 25953401 [TBL] [Abstract][Full Text] [Related]
8. New Toxicology Tools and the Emerging Paradigm Shift in Environmental Health Decision-Making. Ginsberg GL; Pullen Fedinick K; Solomon GM; Elliott KC; Vandenberg JJ; Barone S; Bucher JR Environ Health Perspect; 2019 Dec; 127(12):125002. PubMed ID: 31834829 [TBL] [Abstract][Full Text] [Related]
9. Derivation of point of departure (PoD) estimates in genetic toxicology studies and their potential applications in risk assessment. Johnson GE; Soeteman-Hernández LG; Gollapudi BB; Bodger OG; Dearfield KL; Heflich RH; Hixon JG; Lovell DP; MacGregor JT; Pottenger LH; Thompson CM; Abraham L; Thybaud V; Tanir JY; Zeiger E; van Benthem J; White PA Environ Mol Mutagen; 2014 Oct; 55(8):609-23. PubMed ID: 24801602 [TBL] [Abstract][Full Text] [Related]
10. Developmental toxicology: new directions workshop: refining testing strategies and study designs. Brannen KC; Fenton SE; Hansen DK; Harrouk W; Kim JH; Shuey D Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):404-12. PubMed ID: 22006510 [TBL] [Abstract][Full Text] [Related]
11. Empirical analysis of BMD metrics in genetic toxicology part I: in vitro analyses to provide robust potency rankings and support MOA determinations. Wills JW; Johnson GE; Doak SH; Soeteman-Hernández LG; Slob W; White PA Mutagenesis; 2016 May; 31(3):255-63. PubMed ID: 26687511 [TBL] [Abstract][Full Text] [Related]
12. Need and potential value of the Pig-ain vivo mutation assay-a HESI perspective. Schuler M; Gollapudi BB; Thybaud V; Kim JH Environ Mol Mutagen; 2011 Dec; 52(9):685-9. PubMed ID: 21976154 [TBL] [Abstract][Full Text] [Related]
13. Dose-dependent transitions in mechanisms of toxicity. Slikker W; Andersen ME; Bogdanffy MS; Bus JS; Cohen SD; Conolly RB; David RM; Doerrer NG; Dorman DC; Gaylor DW; Hattis D; Rogers JM; Setzer RW; Swenberg JA; Wallace K Toxicol Appl Pharmacol; 2004 Dec; 201(3):203-25. PubMed ID: 15582645 [TBL] [Abstract][Full Text] [Related]
14. MutAIT: an online genetic toxicology data portal and analysis tools. Avancini D; Menzies GE; Morgan C; Wills J; Johnson GE; White PA; Lewis PD Mutagenesis; 2016 May; 31(3):323-8. PubMed ID: 26208916 [TBL] [Abstract][Full Text] [Related]
15. Relevance and follow-up of positive results in in vitro genetic toxicity assays: an ILSI-HESI initiative. Thybaud V; Aardema M; Casciano D; Dellarco V; Embry MR; Gollapudi BB; Hayashi M; Holsapple MP; Jacobson-Kram D; Kasper P; MacGregor JT; Rees R Mutat Res; 2007 Oct; 633(2):67-79. PubMed ID: 17616430 [TBL] [Abstract][Full Text] [Related]
16. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing. Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E; Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066 [TBL] [Abstract][Full Text] [Related]
18. Approaches to evaluating the toxicity and carcinogenicity of man-made fibers: summary of a workshop held November 11-13, 1991, Durham, North Carolina. McClellan RO; Miller FJ; Hesterberg TW; Warheit DB; Bunn WB; Kane AB; Lippmann M; Mast RW; McConnell EE; Reinhardt CF Regul Toxicol Pharmacol; 1992 Dec; 16(3):321-64. PubMed ID: 1293648 [TBL] [Abstract][Full Text] [Related]
19. Regulatory aspects of genotoxicity testing: from hazard identification to risk assessment. Blakey D; Galloway SM; Kirkland DJ; MacGregor JT Mutat Res; 2008 Nov; 657(1):84-90. PubMed ID: 18926925 [TBL] [Abstract][Full Text] [Related]
20. HESI workshop summary: Interpretation of developmental and reproductive toxicity endpoints and the impact on data interpretation of adverse events. Green ML; Kluever A; Chen C; Dobreniecki S; Halpern W; Hannas B; Hoberman A; McNerney ME; Mitchell-Ryan S; Shafer TJ; Van Cruchten S; White T Birth Defects Res; 2024 Feb; 116(2):e2311. PubMed ID: 38343152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]